The immune scores for the high MIDN‐expression cancers (including GBM, LUAD, BRCA, TGCT, THYM, SKCM, KIRP, SARC, LUSC, ACC, ESCA, and STAD) were significantly lower than those with low MIDN expression. Here, MIDN is linked to cancer.